The views expressed in this blog post belong solely to its author and do not necessarily reflect the views of PLOS or…
-
post Opinion: Who should lead WHO (Pt 1 of 3)? Dr. Tedros, nominee of the Government of Ethiopia.Read more
-
Open Access Repost: The Top Ten Ways to Tell that a Journal is FakeRead more
[PLOSBLOGS note: We’re republishing this popular post in light of recent coverage on the subject, “A Scholarly Sting Operation Shines a Light on ‘Predatory&rsquo…
-
Autism Researcher ‘First Person’: Why Context Matters When Assessing Autistic TraitsRead more
PLOSBLOGS Editor’s Note: From time to time we feature “first person” blog posts by PLOS journal authors, particularly when their newly published…
-
post Ending a Global Epidemic: Tuberculosis in Children #UnitetoEndTBRead more
“When my daughter got sick, I took her to a clinic in my neighborhood. They gave her cough syrup for seven days…
-
Global health The U.S. Needs a Lesson in Food Policy from Mexico by Daniel Taber, PhD, MPHRead more
What do you tell people when you’re an invited “expert,” yet in some ways you’re the dumbest person in the room? That…
-
Global health From the archives: A Story of 20,000 Healthy Mothers and Babies by Dr. Nosakhare OrobatonRead more
[Originally published as a PLOS BLOGS Network guest post on December 10, 2013] By Dr. Nosakhare Orobaton To mark Year Three of the…
-
Global health Known Knowns and Unknowns of U.S. Drug PricingRead more
By Joshua P. Cohen Research Associate Professor, Tufts Center for the Study of Drug Development (Full bio below this post) Media scrutiny…
-
Autism NeuroTribes, Steve Silberman on a haunting history and new hope for autistic peopleRead more
[Congratulations to Steve Silberman, just awarded the 2015 Samuel Johnson Prize, UK’s top nonfiction award for NeuroTribes. This interview with Silberman by Emily…
-
ethics Talking drug prices, Pt 6: Openness vs. secrecy in drug development By Mat ToddRead more
Welcome to the sixth and final post in a PLOS BLOGS series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of…
-
Global health Talking Drug Prices, Pt 5: Double-billed… By Manica Balasegaram, MSFRead more
Welcome to part five in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our…
-
post Talking Drug Prices, Pt 4 Drug pricing is out of control, what should be done? By James LoveRead more
Welcome to part four in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of our…
-
ethics Talking Drug Prices, Pt. 3 If you play with scorpions, don’t be surprised when you get stung by Atif KukaswadiaRead more
Welcome to the third in a PLOS BLOGS six-part series, Talking about Drug Prices & Access to Medicines. To borrow a phrase from one of…